Brief: Ose Immunotherapeutics Granted New Patent From EPO Covering CLEC-1

Ose Immunotherapeutics SA

02/05/2022 06:38

May 2 (Reuters) - OSE Immunotherapeutics SA  OSE.PA :
    * ANNOUNCES NEW EUROPEAN PATENT GRANTED COVERING CLEC-1,
NOVEL
MYELOID IMMUNE CHECKPOINT TARGET FOR CANCER IMMUNOTHERAPY
    * PATENT ALSO GRANTED IN JAPAN AND NOTICE OF ALLOWANCE
GRANTED IN
US
    * EPO PATENT PROVIDES A PROTECTION UNTIL 2037

Source text for Eikon:  urn:newsml:reuters.com:*:nGNXbxCm0x
Further company coverage:  OSE.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 772 09 20;))